TimeScale Financial’s AstraZeneca AZN Stock Holding History

TimeScale Financial’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$5.44K	Hold	38	–	–	﹤0.01%	421
2023 Q1	$5.28K	Sell	38 -80	-68%	-$10.8K	﹤0.01%	411
2022 Q4	$12.9K	Hold	118	–	–	﹤0.01%	263
2022 Q3	$13K	Buy	118 +80	+211%	+$10.1K	﹤0.01%	260
2022 Q2	$5K	Hold	38	–	–	﹤0.01%	355
2022 Q1	$5K	Hold	38	–	–	﹤0.01%	372
2021 Q4	$4K	Hold	38	–	–	﹤0.01%	389
2021 Q3	$5K	Buy	+38	New	+$4.42K	﹤0.01%	365

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TimeScale Financial's AZN Position: Q2 2023 in Review

TimeScale Financial held its AstraZeneca (AZN) position steady in Q2 2023 at 38 shares worth $5.44K. The position accounts for ﹤0.01% of the portfolio, ranked #421.

TimeScale Financial first reported a position in AZN in Q3 2021 and has held it in 8 quarters since. The position peaked at $13K in Q3 2022. 1,091 funds tracked by Wall St. Rank hold AZN as of Q2 2023.

TimeScale Financial held 38 shares of AstraZeneca worth $5.44K as of Q2 2023.
TimeScale Financial left its AstraZeneca share count unchanged in Q2 2023.
AstraZeneca made up ﹤0.01% of TimeScale Financial's portfolio in Q2 2023, its #421 holding.
TimeScale Financial first reported a position in AstraZeneca in Q3 2021 and has held it in 8 quarters since.
TimeScale Financial's AstraZeneca position peaked at $13K in Q3 2022.
1,091 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.